S
StrainX Bioworks
Sustainable biomolecules via precision fermentation for various industries.
About StrainX Bioworks
StrainX Bioworks is a synthetic biology company leveraging precision fermentation to produce high-value biomolecules for the food, nutraceutical, and beauty industries. The company was founded in 2023 by Akshay Mittal (CEO) and Dr. Alok Malaviya (CTO), both alumni of IIT Delhi. After operating in stealth mode for two years to build its integrated biotechnology platform, StrainX has emerged with significant capabilities in strain engineering, fermentation processes, and product development. The firm's core technology revolves around engineering microorganisms, such as bacteria and yeast, to create alternative proteins, enzymes, and bioengineered metabolites sustainably and at scale. This approach reduces reliance on traditional animal or plant-based sourcing. StrainX serves business-to-business (B2B) clients, including global food and beverage companies and ingredient suppliers, by offering clean-label solutions and functional ingredients that enhance taste, texture, and nutrition. Its business model is built on an integrated platform that handles the entire process from technology development and scale-up to manufacturing and commercialization. The company has demonstrated fermentation at a 10,000-liter scale and is planning to expand to 100,000-liter operations. Its product applications include functional ingredients for food, health-promoting compounds for nutraceuticals, and innovative actives for cosmetics. In May 2026, StrainX Bioworks announced it had raised $13 million in a funding round co-led by Prime Venture Partners and Leo Capital, with participation from other investors. The capital is intended to expand its R&D capabilities, scale its fermentation infrastructure in Bhopal, and accelerate global commercialization, with initial target markets in India and the US. The company has already received self-affirmed GRAS (Generally Recognized as Safe) status for one of its ingredients in the US. Keywords: synthetic biology, precision fermentation, biomolecules, alternative proteins, strain engineering, sustainable ingredients, food technology, nutraceuticals, microbial fermentation, B2B ingredients, bio-manufacturing, food additives, cosmetic ingredients, clean label solutions, bioactives, enzymes, metabolites, biotechnology, Akshay Mittal, Alok Malaviya.
Source: Dealroom company dataLatest news
Press, funding announcements and product moves mentioning StrainX Bioworks.
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | May 2026 | $13M | $52M | Dholakia Ventures · SunICON · Leo Capital · Good Startup | ↗ |
Growth signals
Latest recorded traffic for StrainX Bioworks is 2.8K monthly website visits.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
| Company | Headquarters | Status | Employees | Total funding | Valuation |
|---|---|---|---|---|---|
BIOCOLLUpcoming fungal platform for cost-effective, animal-free collagen production |
Espoo, Finland | Operational | 4 | — | — |
Anomaly BioEngineering microbes into bio-based ingredient micro-factories to replace fragile global supply chains. |
Singapore | Operational | |||
MiracclEngineered protein for natural, zero-calorie sweetness. |
— | Operational | |||
ChangingBioMicrobial proteins for sustainable dairy alternative ingredients |
China | Operational | |||
NoPalm IngredientsFermentation-based palm oil alternative from upcycled sidestreams. |
Wageningen, Netherlands | Operational | |||
The Aspire BiozymesFunctional ingredients for nutrition and pharmaceutical industries. |
— | Operational | |||
IDEA Bio - Integrated Design Environment for Advanced biomanufacturingSynthetic biology services for advanced biomanufacturing solutions. |
Australia | Operational | |||
NovanoroComputational biosynthesis for high-value molecule production. |
— | Operational |
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A6 investors entered at this stage
Leo Capital
Prime Venture Partners
Dholakia Ventures
SunICON
Good Startup
Sparrow Capital
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about StrainX Bioworks on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See StrainX Bioworks’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







